Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease

T Athar, K Al Balushi, SA Khan - Molecular biology reports, 2021 - Springer
Alzheimer's disease (AD) is a neurodegenerative old age disease that is complex,
multifactorial, unalterable, and progressive in nature. The currently approved therapy …

Alzheimer's disease, dementia, and stem cell therapy

T Duncan, M Valenzuela - Stem cell research & therapy, 2017 - Springer
Alzheimer's disease (AD) represents arguably the most significant social, economic, and
medical crisis of our time. Characterized by progressive neurodegenerative pathology, AD is …

In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model

Z Guo, L Zhang, Z Wu, Y Chen, F Wang, G Chen - Cell stem cell, 2014 - cell.com
Loss of neurons after brain injury and in neurodegenerative disease is often accompanied
by reactive gliosis and scarring, which are difficult to reverse with existing treatment …

Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model

P Rivetti Di Val Cervo, RA Romanov, G Spigolon… - Nature …, 2017 - nature.com
Cell replacement therapies for neurodegenerative disease have focused on transplantation
of the cell types affected by the pathological process. Here we describe an alternative …

Direct lineage reprogramming: strategies, mechanisms, and applications

J Xu, Y Du, H Deng - Cell stem cell, 2015 - cell.com
The direct lineage reprogramming of one specialized cell type into another using defined
factors has fundamentally re-shaped traditional concepts regarding the epigenetic stability of …

Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience

J Mertens, MC Marchetto, C Bardy… - Nature Reviews …, 2016 - nature.com
The scarcity of live human brain cells for experimental access has for a long time limited our
ability to study complex human neurological disorders and elucidate basic neuroscientific …

[HTML][HTML] Making neurons, made easy: The use of Neurogenin-2 in neuronal differentiation

AJ Hulme, S Maksour, MSC Glover, S Miellet, M Dottori - Stem Cell Reports, 2022 - cell.com
Directed neuronal differentiation of human pluripotent stem cells (hPSCs), neural
progenitors, or fibroblasts using transcription factors has allowed for the rapid and highly …

How to make a midbrain dopaminergic neuron

E Arenas, M Denham, JC Villaescusa - Development, 2015 - journals.biologists.com
Midbrain dopaminergic (mDA) neuron development has been an intense area of research
during recent years. This is due in part to a growing interest in regenerative medicine and …

Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons

ML Liu, T Zang, Y Zou, JC Chang, JR Gibson… - Nature …, 2013 - nature.com
Cell fate can be reprogrammed by modifying intrinsic and extrinsic cues. Here we show that
two small molecules (forskolin and dorsomorphin) enable the transcription factor …

Neural stem cell‐based treatment for neurodegenerative diseases

SU Kim, HJ Lee, YB Kim - Neuropathology, 2013 - Wiley Online Library
Human neurodegenrative diseases such as P arkinson's disease (PD), H untington's
disease (HD), amyotrophic lateral sclerosis (ALS) and A lzheimer's disease (AD) are caused …